. 2015 Jun 29;9:3361–3368. doi: 10.2147/DDDT.S86344

Table 6.

Dynamics of C-reactive protein, interleukin-6, and plasminogen activator inhibitor in patients with myocardial infarction during in-hospital period

Variable	Control (n=33)	Group 1: patients given atorvastatin 20 mg/day (n=110)		Group 2: patients given atorvastatin 40 mg/day (n=100)
Variable	Control (n=33)	Day 1	Day 12	Day 1	Day 12
C-reactive protein (mg/L)	1.00 (0.8; 1.5)	20.2 (10.9; 35.0)^a	21.9 (18.9; 25.4)^a,^c	25.5 (23.2; 27.1)^a	7.7 (4.0; 17.0)^a–^c
Interleukin-6 (pg/mL)	2.65 (2.1; 3.4)	19.5 (13.7; 25.3)^a	11.7 (10.2; 15.4)^a,^c	21.9 (20.1; 22.2)^a	12.1 (11.2; 13.0)^a,^c
Plasminogen activator inhibitor-1 (pg/mL)	35.3 (32.1; 43.2)	125.9 (112.5; 156.6)^a	81.4 (75.6; 92.5)^a,^c	136.3 (124.2; 145.1)^a	80.3 (68.2; 88.9)^c

Notes:

Significant difference from control (P<0.05).

Significant difference in indicator among groups on the 12th day.

Significant difference in indicator within the group on the first and 12th days.